Introduction: Women with type 2 diabetes are at risk of commencing pregnancy while using medications that are either not recommended for pregnancy or with known teratogenicity, which may contribute to adverse pregnancy outcomes. In this study, we aimed to characterize pregnancy-related risk factors and medication exposures among women with type 2 diabetes.

Research Design And Methods: Individual health characteristics, sociodemographic information, and prescription data were extracted from the primary care records of women aged 18-45 years with type 2 diabetes in participating general practices in the UK. Prescribed medications were categorized according to suitability for pregnancy: recommended, not recommended, or not recommended but used if clinically indicated. Logistic regression was used to estimate associations between individual characteristics and medications not recommended for pregnancy.

Results: Data on 725 women were extracted. Prescribed medications suggested the presence of numerous comorbidities, with diabetes medications (65%, n=471) and statins (20%, n=145) most frequently prescribed. 37% (n=268) of women took ≥3 medications, and a third (n=269) took medications not recommended for pregnancy. Among those not prescribed contraception (89%, n=646), no one met all clinically recommended pre-pregnancy criteria. In multivariable logistic regression analysis, polypharmacy (OR 3.49 95% CI 2.88 to 4.30) and age (OR 1.04 95% CI 1.00 to 1.09) were associated with use of medications not recommended for pregnancy.

Conclusions: Women with type 2 diabetes have suboptimal contraceptive provision despite multiple exposures to medications not recommended for pregnancy. Regular assessment of contraceptive use, reproductive intentions, and medication review is urgently needed in primary care settings to minimize pregnancy-related risks.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11883600PMC
http://dx.doi.org/10.1136/bmjdrc-2024-004312DOI Listing

Publication Analysis

Top Keywords

medications recommended
20
women type
16
type diabetes
16
primary care
12
recommended pregnancy
12
medications
9
recommended
9
pregnancy-related risk
8
risk factors
8
prescribed medications
8

Similar Publications

Background: Flexible optical intubation (FOI) is the preferred technique for managing anticipated difficult airways, particularly in awake patients when anatomical factors complicate conventional laryngoscopy. Mastering the procedure requires skills, but a comprehensive overview of the evidence on training and assessment of FOI skills is lacking. There is no evidence-based consensus on educational strategies and recommendations for skill acquisition and retention, thus highlighting a significant gap in airway management training.

View Article and Find Full Text PDF

Objective: To investigate the application of whole exome sequencing (WES) in the prenatal diagnosis of isolated fetal growth restriction (FGR) with a normal result by chromosomal microarray analysis (CMA).

Methods: This retrospective study included singleton fetuses with isolated FGR in Guangdong Women and Children Hospital between July 2018 and August 2023. All fetuses were subjected to invasive prenatal testing with CMA and WES.

View Article and Find Full Text PDF
Article Synopsis
  • Self-medication among kidney transplant patients poses risks to their health, with 80.3% of participants engaging in this practice shortly after discharge.
  • Common self-medicated substances include NSAIDs, sleeping pills, and heartburn medications, with 18.2% participating in risky self-medication behaviors.
  • The study emphasizes the need for better patient education on the dangers of self-medication and suggests promoting safer alternatives and consulting healthcare providers.
View Article and Find Full Text PDF

Objective: this trial aimed to determine the effects of probiotic supplementation on weight loss and lipid profiles in hypercholesterolemic obese patients.

Methods: ın this pilot randomized, double-blind, placebo-controlled trial, hypercholesterolemic obese patients (BMI = 30.0-35.

View Article and Find Full Text PDF

The use of non-sugar sweeteners (NSS) has gained prominence as an alternative to reduce free sugar consumption, aligning with global efforts to combat the growing prevalence of non-communicable diseases (NCDs). By providing sweetness without caloric energy, NSS are viewed as potential tools in addressing diet-related health challenges. However, their long-term effects on health remain contentious, especially within the medical community.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!